{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:58:41Z","timestamp":1785355121057,"version":"3.55.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,7]]},"abstract":"\n Rationale:<\/jats:title>\n Psoriasis is a chronic, inflammatory dermatosis with a complex pathogenesis. Steroid-dependent psoriasis represents a therapeutic challenge, as conventional treatments often yield suboptimal responses and relapse. In traditional Chinese medicine (TCM), psoriasis is categorized as \u201cBai Bi,\u201d and the blood-heat syndrome is a core pathological pattern driving inflammation and progression. However, the efficacy of TCM strategies specifically targeting this syndrome in steroid-dependent cases requires further documentation.<\/jats:p>\n <\/jats:sec>\n \n Patient concerns:<\/jats:title>\n A 68-year-old male presented with a 20-year history of recurrent, widespread erythematosquamous plaques, and severe, refractory pruritus. The condition had acutely exacerbated in the preceding week. Previous long-term therapies with topical corticosteroids and calcipotriol provided only transient improvement with frequent recurrence.<\/jats:p>\n <\/jats:sec>\n \n Diagnoses:<\/jats:title>\n The patient was diagnosed with active-phase, steroid-dependent psoriasis (Western medicine). TCM syndrome differentiation identified a pattern of blood-heat with dampness-wind. Retrospective severity assessment estimated a psoriasis area and severity index score of 16.7 and body surface area involvement of 15%, indicating severe disease.<\/jats:p>\n <\/jats:sec>\n \n Interventions:<\/jats:title>\n A stage-adapted TCM therapeutic strategy was employed, centered on a modified \u201cBuffalo Horn and Rehmannia Decoction\u201d (Shui Jiao Dihuang Tang). The core principle was to cool the blood, resolve toxins, and dispel dampness and wind. The prescription was dynamically adjusted across 3 clinical visits over 3 months based on symptom evolution, including dose modifications of key herbs like Buffalo Horn and the addition of agents to address pruritus, sleep disturbance, and residual hyperpigmentation.<\/jats:p>\n <\/jats:sec>\n \n Outcomes:<\/jats:title>\n Following the 3-month intervention, complete resolution of skin lesions and elimination of pruritus were achieved. The patient maintained clinical remission without recurrence during an 11-month follow-up period, based on self-report.<\/jats:p>\n <\/jats:sec>\n \n Lessons:<\/jats:title>\n This case documents clinical improvement following TCM intervention in steroid-dependent psoriasis. Important limitations include the single-case design, lack of control group, retrospectively estimated psoriasis area and severity index\/body surface area scores, and self-reported long-term outcomes. The observed temporal association between intervention and improvement may reflect natural disease variation, placebo effects, or other confounding factors. While this preliminary observation merits further investigation through rigorous prospective studies, the current evidence level remains limited and cautions against causal interpretation.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/md.0000000000045926","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:01:44Z","timestamp":1762538504000},"page":"e45926","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Treating steroid-dependent psoriasis from the blood-heat syndrome perspective: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3844-3722","authenticated-orcid":false,"given":"Mei-Yang","family":"Jiang","sequence":"first","affiliation":[{"name":"School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu City, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu City, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment.","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R2-20260729","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.3390\/ijms20184347","article-title":"Risk factors for the development of psoriasis.","volume":"20","author":"Kamiya","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"122991","DOI":"10.1016\/j.lfs.2024.122991","article-title":"Advances in psoriasis research: from pathogenesis to therapeutics.","volume":"355","author":"Sugumaran","year":"2024","journal-title":"Life Sci"},{"key":"R4-20260729","first-page":"880","article-title":"Research progress on basic and applied studies of buffalo horn as an animal-derived traditional Chinese medicine.","volume":"38","author":"Tang","year":"2022","journal-title":"J Nanjing Univ Chin Med"},{"key":"R5-20260729","first-page":"5389","article-title":"Potential risk assessment of Chinese patent medicines containing pyrrolizidine alkaloids.","volume":"52","author":"Xiong","year":"2021","journal-title":"Chin Tradit Herb. Drugs"},{"key":"R6-20260729","first-page":"835","article-title":"Exploring the anti-inflammatory effects of berberine in metabolic diseases based on gut microbiota (English).","volume":"47","author":"Xiao","year":"2020","journal-title":"Prog Biochem Biophys"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence.","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R8-20260729","doi-asserted-by":"crossref","first-page":"154384","DOI":"10.1016\/j.phymed.2022.154384","article-title":"Combining network pharmacology, RNA-seq, and metabolomics strategies to reveal the mechanism of Cimicifugae Rhizoma \u2013 Smilax glabra Roxb herb pair for the treatment of psoriasis.","volume":"105","author":"Hu","year":"2022","journal-title":"Phytomedicine"},{"key":"R9-20260729","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis-current concepts in pathogenesis.","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"R10-20260729","first-page":"113","article-title":"Comorbid psoriasis and metabolic syndrome: clinical implications and optimal management.","volume":"12","author":"De Brandt","year":"2022","journal-title":"Psoriasis (Auckl)"},{"key":"R11-20260729","first-page":"493","article-title":"Efficacy and safety of external application of Chinese herbal medicine for psoriasis vulgaris: a systematic review of randomized controlled trials.","volume":"42","author":"Yi","year":"2022","journal-title":"J Tradit Chin Med"},{"key":"R12-20260729","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.36849\/JDD.6040","article-title":"An overview of biologics for psoriasis.","volume":"20","author":"Dave","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"R13-20260729","doi-asserted-by":"crossref","first-page":"e32360","DOI":"10.1097\/MD.0000000000032360","article-title":"Integrative medicine (East Asian herbal medicine combined with conventional medicine) for psoriasis: a protocol for systematic review and meta-analysis.","volume":"102","author":"Kim","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R14-20260729","doi-asserted-by":"crossref","first-page":"8942301","DOI":"10.1155\/2020\/8942301","article-title":"Efficacy and safety of Jueyin granules for patients with mild-to-moderate psoriasis vulgaris: protocol for a multicenter randomized placebo-controlled trial.","volume":"2020","author":"Li","year":"2020","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:03:02Z","timestamp":1785351782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":14,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045926","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"2025-08-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}